<VariationArchive VariationID="208427" VariationName="NM_021939.4(FKBP10):c.877_879del (p.Tyr293del)" VariationType="Deletion" Accession="VCV000208427" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-04-20" DateCreated="2015-08-31" MostRecentSubmission="2024-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="204645" VariationID="208427">
      <GeneList>
        <Gene Symbol="FKBP10" FullName="FKBP prolyl isomerase 10" GeneID="60681" HGNC_ID="HGNC:18169" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="41813004" stop="41823213" display_start="41813004" display_stop="41823213" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="39968961" stop="39979468" display_start="39968961" display_stop="39979468" Strand="+" />
          </Location>
          <OMIM>607063</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_021939.4(FKBP10):c.877_879del (p.Tyr293del)</Name>
      <CanonicalSPDI>NC_000017.11:41819356:ACTAC:AC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="41819357" stop="41819359" display_start="41819357" display_stop="41819359" variantLength="3" positionVCF="41819356" referenceAlleleVCF="CACT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="39975609" stop="39975611" display_start="39975609" display_stop="39975611" variantLength="3" positionVCF="39975608" referenceAlleleVCF="CACT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>Y293del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.39975611_39975613del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.39975611_39975613del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.41819359_41819361del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.41819359_41819361del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015860.1" sequenceAccession="NG_015860" sequenceVersion="1" change="g.11650_11652del">
            <Expression>NG_015860.1:g.11650_11652del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021939.4" sequenceAccession="NM_021939" sequenceVersion="4" change="c.877_879del" MANESelect="true">
            <Expression>NM_021939.4:c.877_879del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_068758.3" sequenceAccession="NP_068758" sequenceVersion="3" change="p.Tyr293del">
            <Expression>NP_068758.3:p.Tyr293del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_12" sequenceAccession="LRG_12">
            <Expression>LRG_12:g.11650_11652del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021939.3" sequenceAccession="NM_021939" sequenceVersion="3" change="c.877_879delTAC">
            <Expression>NM_021939.3:c.877_879delTAC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_12t1" sequenceAccession="LRG_12t1">
            <Expression>LRG_12t1:c.877_879del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021939.4" sequenceAccession="NM_021939" sequenceVersion="4" change="c.877_879delTAC" MANESelect="true">
            <Expression>NM_021939.4:c.877_879delTAC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA358713" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607063.0012" DB="OMIM" />
        <XRef Type="rs" ID="869320752" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_021939.4(FKBP10):c.877_879del (p.Tyr293del) AND Bruck syndrome 1" Accession="RCV000190460" Version="2">
        <ClassifiedConditionList TraitSetID="9310">
          <ClassifiedCondition DB="MedGen" ID="C1850168">Bruck syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_021939.4(FKBP10):c.877_879del (p.Tyr293del) AND not provided" Accession="RCV000598565" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_021939.4(FKBP10):c.877_879del (p.Tyr293del) AND Osteogenesis imperfecta" Accession="RCV003993877" Version="1">
        <ClassifiedConditionList TraitSetID="5689">
          <ClassifiedCondition DB="MedGen" ID="C0029434">Osteogenesis imperfecta</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-23" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-08-31" MostRecentSubmission="2024-04-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23712425</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9310" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1068" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bruck syndrome 1</ElementValue>
                <XRef ID="Bruck+Syndrome+1/980" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009806" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kuskokwim disease</ElementValue>
                <XRef ID="Kuskokwim+disease/4053" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arthrogryposis-like disorder</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BRKS1</ElementValue>
                <XRef Type="MIM" ID="259450" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1029" />
                <XRef ID="1029" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <XRef ID="1149" DB="Orphanet" />
              <XRef ID="2771" DB="Orphanet" />
              <XRef ID="C1850168" DB="MedGen" />
              <XRef ID="MONDO:0009806" DB="MONDO" />
              <XRef Type="MIM" ID="259450" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5689" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6312" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta</ElementValue>
                <XRef ID="Osteogenesis+imperfecta/5451" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019019" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS166200" DB="OMIM" />
                <XRef ID="78314001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1017" />
                <XRef ID="1017" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2006">
                <ID Source="pmc">3110960</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111019</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0029434" DB="MedGen" />
              <XRef ID="D010013" DB="MeSH" />
              <XRef ID="MONDO:0019019" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS166200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="453304" SubmissionDate="2015-08-28" DateLastUpdated="2015-08-31" DateCreated="2015-08-31">
        <ClinVarSubmissionID localKey="607063.0012_BRUCK SYNDROME 1" title="FKBP10, 3-BP DEL, 877TAC_BRUCK SYNDROME 1" />
        <ClinVarAccession Accession="SCV000245338" DateUpdated="2015-08-31" DateCreated="2015-08-31" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of multiple pedigrees with Kuskokwim disease (BRKS1; 259450), Barnes et al. (2013) identified a homozygous 3-bp deletion in exon 5 of the FKBP10 gene (c.877_879delTAC, NM_021939.3) resulting in the deletion of a highly conserved tyrosine residue (Tyr293del) in the third peptidyl-prolyl cis-trans isomerase domain. Three percent (3/96 alleles) of controls in the Kuskokwim region were shown to be carriers of the Tyr293 variant.</Attribute>
              <Citation>
                <ID Source="PubMed">23712425</ID>
              </Citation>
              <XRef DB="OMIM" ID="259450" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKBP10" />
          </GeneList>
          <Name>FKBP10, 3-BP DEL, 877TAC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 877TAC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607063.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BRUCK SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1389881" SubmissionDate="2022-12-28" DateLastUpdated="2022-12-31" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="GDXSV:253847" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000709875" DateUpdated="2022-12-31" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>In-frame deletion of 1 amino acid in a non-repeat region; Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 23712425, 34173012)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKBP10" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:435625</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_021939.3:c.877_879del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_154_20221228054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8997813" SubmissionDate="2024-04-03" DateLastUpdated="2024-04-15" DateCreated="2024-04-15">
        <ClinVarSubmissionID localKey="NM_021939.4:c.877_879delTAC|MedGen:C0029434" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004813218" DateUpdated="2024-04-15" DateCreated="2024-04-15" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23712425</ID>
          </Citation>
          <Comment>Variant summary: FKBP10 c.877_879delTAC (p.Tyr293del) results in an in-frame deletion that is predicted to remove one amino acid in the FKBP-type peptidyl-prolyl cis-trans isomerase domain (IPR001179) from the encoded protein. The variant was absent in 251136 control chromosomes. c.877_879delTAC has been reported at a homozygous state in the literature in multiple individuals affected with Kuskokwim syndrome. These data indicate that the variant is very likely to be associated with disease (Barnes_2013). At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in a residual 5% of normal FKBP65 protein levels due to destability and compromised hydroxylation levels of the telopeptide lysine in fibroblasts from patients with the homozygous variant (Barnes_2013). The following publication has been ascertained in the context of this evaluation (PMID: 23712425).ClinVar contains an entry for this variant (Variation ID: 208427). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKBP10" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_021939.4:c.877_879delTAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0029434" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14342304</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="453304" TraitType="Disease" MappingType="Name" MappingValue="BRUCK SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C1850168" Name="Bruck syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1389881" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8997813" TraitType="Disease" MappingType="XRef" MappingValue="C0029434" MappingRef="MedGen">
        <MedGen CUI="C0029434" Name="Osteogenesis imperfecta" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

